Skip to main content
Top
Published in: Rheumatology International 10/2021

01-10-2021 | Etanercept | Case Based Review

Aseptic meningitis in rheumatoid arthritis after anti-TNF administration: a case-based literature review

Authors: Reşit Yıldırım, Döndü Üsküdar Cansu, Deniz Arık, Suzan Saylısoy, Cengiz Korkmaz

Published in: Rheumatology International | Issue 10/2021

Login to get access

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by articular and extra-articular manifestations. Among extra-articular involvement, rheumatoid meningitis (RM) is a rare condition, which may exhibit variable symptoms including headache, focal and/or generalized neurologic deficits. It may develop as the preceding manifestation of RA or occur at any time of the disease course. Some drugs used for the treatment of RA may give rise to aseptic meningitis or create a tendency to infectious meningitis due to their immunosuppressive effect. All these possibilities may lead to difficulties in the differential diagnosis. Achieving a diagnosis in a short time is crucial in terms of prognosis. Here, we would like to report a case with longstanding RA manifested by left-sided weakness and seizure shortly after initiating etanercept (ETA) therapy. ETA-induced meningitis was confirmed with appropriate diagnostic tools. Our aim with this case-based review is to attract the attention of this rare condition and discuss diagnostic challenges.
Literature
2.
go back to reference Parsons AM, Aslam F, Grill MF, Aksamit AJ, Goodman BP (2020) Rheumatoid meningitis: clinical characteristics, diagnostic evaluation, and treatment. Neurohospitalist 10(2):88–94CrossRefPubMed Parsons AM, Aslam F, Grill MF, Aksamit AJ, Goodman BP (2020) Rheumatoid meningitis: clinical characteristics, diagnostic evaluation, and treatment. Neurohospitalist 10(2):88–94CrossRefPubMed
3.
go back to reference Atzeni F, Talotta R, Masala IF, Gerardi MC, Casale R, Sarzi-Puttini P (2018) Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents. Best Pract Res ClinRheumatol 32(4):500–510CrossRef Atzeni F, Talotta R, Masala IF, Gerardi MC, Casale R, Sarzi-Puttini P (2018) Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents. Best Pract Res ClinRheumatol 32(4):500–510CrossRef
5.
go back to reference Ahmed M, Luggen M, Herman JH, Weiss KL, Decourten-Myers G, Quinlan JG, Khanna D (2006) Hypertrophic pachymeningitis in rheumatoid arthritis after adalimumab administration. J Rheumatol 33(11):2344–2346PubMed Ahmed M, Luggen M, Herman JH, Weiss KL, Decourten-Myers G, Quinlan JG, Khanna D (2006) Hypertrophic pachymeningitis in rheumatoid arthritis after adalimumab administration. J Rheumatol 33(11):2344–2346PubMed
6.
go back to reference Seago S, Stroberg E, Metting A (2016) Rheumatoid meningitis associated with infliximab. Proc (BaylUniv Med Cent) 29(2):204–206 Seago S, Stroberg E, Metting A (2016) Rheumatoid meningitis associated with infliximab. Proc (BaylUniv Med Cent) 29(2):204–206
7.
go back to reference Durel CA, Feurer E, Pialat JB, Berthoux E, Chapurlat RD, Confavreux CB (2013) Etanercept may induce neurosarcoidosis in a patient treated for rheumatoid arthritis. BMC Neurol 28(13):212CrossRef Durel CA, Feurer E, Pialat JB, Berthoux E, Chapurlat RD, Confavreux CB (2013) Etanercept may induce neurosarcoidosis in a patient treated for rheumatoid arthritis. BMC Neurol 28(13):212CrossRef
8.
go back to reference Wright WF, Pinto CN, Palisoc K, Baghli S (2019) Viral (aseptic) meningitis: a review. J NeurolSci 398:176–183 Wright WF, Pinto CN, Palisoc K, Baghli S (2019) Viral (aseptic) meningitis: a review. J NeurolSci 398:176–183
9.
go back to reference Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. RheumatolInt 31:1409–1417CrossRef Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. RheumatolInt 31:1409–1417CrossRef
10.
go back to reference Gherghel N, Stan A, Stan H (2018) Pearls & Oy-sters: rheumatoid meningitis occurring during treatment with etanercept. Neurology 91(17):806–808CrossRefPubMed Gherghel N, Stan A, Stan H (2018) Pearls & Oy-sters: rheumatoid meningitis occurring during treatment with etanercept. Neurology 91(17):806–808CrossRefPubMed
11.
12.
go back to reference Huys AC, Guerne PA, Horvath J (2012) Rheumatoid meningitis occurring during adalimumab and methotrexate treatment. Joint Bone Spine 79(1):90–92CrossRefPubMed Huys AC, Guerne PA, Horvath J (2012) Rheumatoid meningitis occurring during adalimumab and methotrexate treatment. Joint Bone Spine 79(1):90–92CrossRefPubMed
13.
go back to reference Chou RC, Henson JW, Tian D, Hedley-Whyte ET, Reginato AM (2006) Successful treatment of rheumatoid meningitis with cyclophosphamide but not infliximab. Ann Rheum Dis 65(8):1114–1116CrossRefPubMedPubMedCentral Chou RC, Henson JW, Tian D, Hedley-Whyte ET, Reginato AM (2006) Successful treatment of rheumatoid meningitis with cyclophosphamide but not infliximab. Ann Rheum Dis 65(8):1114–1116CrossRefPubMedPubMedCentral
14.
go back to reference Nihat A, Chinthapalli K, Bridges L, Johns P, Sofat N, Moynihan B (2016) Rheumatoid meningitis. PractNeurol 16(4):312–314 Nihat A, Chinthapalli K, Bridges L, Johns P, Sofat N, Moynihan B (2016) Rheumatoid meningitis. PractNeurol 16(4):312–314
15.
go back to reference Qin Z, Kim J, Valencia D, Hamoodi L, Neltner J, Sizemore T, Lightfoot R Jr (2020) Rheumatoid meningitis: a case report and review of the literature. NeurolClinPract 10(1):73–83 Qin Z, Kim J, Valencia D, Hamoodi L, Neltner J, Sizemore T, Lightfoot R Jr (2020) Rheumatoid meningitis: a case report and review of the literature. NeurolClinPract 10(1):73–83
16.
go back to reference Marotte H, Charrin JE, Miossec P (2001) Infliximab-induced aseptic meningitis. Lancet 358(9295):1784CrossRefPubMed Marotte H, Charrin JE, Miossec P (2001) Infliximab-induced aseptic meningitis. Lancet 358(9295):1784CrossRefPubMed
17.
go back to reference Cavazzana I, Taraborelli M, Fredi M, Tincani A, Franceschini F (2014) Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis. ClinExpRheumato 32(5):732–734 (Epub 2014 Sep 8) Cavazzana I, Taraborelli M, Fredi M, Tincani A, Franceschini F (2014) Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis. ClinExpRheumato 32(5):732–734 (Epub 2014 Sep 8)
18.
go back to reference Trabelsi M, Romand X, Gilson M, Vaillant M, Guerne PA, Hayem G, Bertolini E, Baillet A, Gaudin P (2020) Rheumatoid meningitis a rare extra-articular manifestation of rheumatoid arthritis: report of 6 cases and literature review. J Clin Med 9(6):1625CrossRefPubMedCentral Trabelsi M, Romand X, Gilson M, Vaillant M, Guerne PA, Hayem G, Bertolini E, Baillet A, Gaudin P (2020) Rheumatoid meningitis a rare extra-articular manifestation of rheumatoid arthritis: report of 6 cases and literature review. J Clin Med 9(6):1625CrossRefPubMedCentral
19.
go back to reference Jazeron A, Lallier JC, Rihn B, Thiercelin MC (2010) Aseptic meningitis possibly induced by adalimumab. Joint Bone Spine 77(6):618–619CrossRefPubMed Jazeron A, Lallier JC, Rihn B, Thiercelin MC (2010) Aseptic meningitis possibly induced by adalimumab. Joint Bone Spine 77(6):618–619CrossRefPubMed
20.
21.
go back to reference Figueroa Rodriguez F, Minkyung K, Jinna S, Farshad S, Davila F (2018) Rheumatoid meningoencephalitis: a feared condition in the era of tnf blockers. Case Rep Rheumatol 2018:4610260PubMedPubMedCentral Figueroa Rodriguez F, Minkyung K, Jinna S, Farshad S, Davila F (2018) Rheumatoid meningoencephalitis: a feared condition in the era of tnf blockers. Case Rep Rheumatol 2018:4610260PubMedPubMedCentral
22.
go back to reference Matsushima M, Yaguchi H, Niino M, Akimoto-Tsuji S, Yabe I, Onishi K, Sasaki H (2010) MRI and pathological findings of rheumatoid meningitis. J ClinNeurosci 17(1):129–132 Matsushima M, Yaguchi H, Niino M, Akimoto-Tsuji S, Yabe I, Onishi K, Sasaki H (2010) MRI and pathological findings of rheumatoid meningitis. J ClinNeurosci 17(1):129–132
23.
go back to reference Starosta MA, Brandwein SR (2007) Clinical manifestations and treatment of rheumatoid pachymeningitis. Neurology 68(13):1079–1080CrossRefPubMed Starosta MA, Brandwein SR (2007) Clinical manifestations and treatment of rheumatoid pachymeningitis. Neurology 68(13):1079–1080CrossRefPubMed
26.
go back to reference Schmid L, Müller M, Treumann T, Arnold W, Möller B, Aeberli D, Villiger PM (2009) Induction of complete and sustained remission of rheumatoid pachymeningitis by rituximab. Arthritis Rheum 60(6):1632–1634CrossRefPubMed Schmid L, Müller M, Treumann T, Arnold W, Möller B, Aeberli D, Villiger PM (2009) Induction of complete and sustained remission of rheumatoid pachymeningitis by rituximab. Arthritis Rheum 60(6):1632–1634CrossRefPubMed
27.
28.
go back to reference Finkelshtein V, Lampl Y, Lorberboym M, Kanner A, Ben-Ami Raichman D, Dabby R, Tanay A (2018) Self-limited rheumatoid meningitis as a presenting symptom of rheumatoid arthritis. Isr Med Assoc J 20(4):262–264PubMed Finkelshtein V, Lampl Y, Lorberboym M, Kanner A, Ben-Ami Raichman D, Dabby R, Tanay A (2018) Self-limited rheumatoid meningitis as a presenting symptom of rheumatoid arthritis. Isr Med Assoc J 20(4):262–264PubMed
29.
go back to reference Li SY, Birnbaum AD, Goldstein DA (2010) Optic neuritis associated with adalimumab in the treatment of uveitis. OculImmunolInflamm 18(6):475–481 Li SY, Birnbaum AD, Goldstein DA (2010) Optic neuritis associated with adalimumab in the treatment of uveitis. OculImmunolInflamm 18(6):475–481
30.
go back to reference Seror R, Richez C, Sordet C, Rist S, Gossec L, Direz G, Houvenagel E, Berthelot JM, Pagnoux C, Dernis E, Melac-Ducamp S, Bouvard B, Asquier C, Martin A, Puechal X, Mariette X; Club Rhumatismes et Inflammation Section of the SFR (2013) Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey. Rheumatology (Oxford) 52(5):868–874CrossRef Seror R, Richez C, Sordet C, Rist S, Gossec L, Direz G, Houvenagel E, Berthelot JM, Pagnoux C, Dernis E, Melac-Ducamp S, Bouvard B, Asquier C, Martin A, Puechal X, Mariette X; Club Rhumatismes et Inflammation Section of the SFR (2013) Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey. Rheumatology (Oxford) 52(5):868–874CrossRef
31.
go back to reference Kunchok A, Aksamit AJ Jr, Davis JM 3rd, Kantarci OH, Keegan BM, Pittock SJ, Weinshenker BG, McKeon A (2020) association between tumor necrosis factor inhibitor exposure and inflammatory central nervous system events. JAMA Neurol 77(8):937–946CrossRefPubMed Kunchok A, Aksamit AJ Jr, Davis JM 3rd, Kantarci OH, Keegan BM, Pittock SJ, Weinshenker BG, McKeon A (2020) association between tumor necrosis factor inhibitor exposure and inflammatory central nervous system events. JAMA Neurol 77(8):937–946CrossRefPubMed
32.
go back to reference Yelehe-Okouma M, Czmil-Garon J, Pape E, Petitpain N, Gillet P (2018) Drug-induced aseptic meningitis: a mini-review. FundamClinPharmacol 32(3):252–260 Yelehe-Okouma M, Czmil-Garon J, Pape E, Petitpain N, Gillet P (2018) Drug-induced aseptic meningitis: a mini-review. FundamClinPharmacol 32(3):252–260
33.
go back to reference Shapiro WR, Young DF (1984) Neurological complications of antineoplastic therapy. ActaNeurolScandSuppl 100:125–132 Shapiro WR, Young DF (1984) Neurological complications of antineoplastic therapy. ActaNeurolScandSuppl 100:125–132
34.
go back to reference Hawboldt J, Bader M (2007) Intramuscular methotrexate-induced aseptic meningitis. Ann Pharmacother 41(11):1906–1911CrossRefPubMed Hawboldt J, Bader M (2007) Intramuscular methotrexate-induced aseptic meningitis. Ann Pharmacother 41(11):1906–1911CrossRefPubMed
35.
go back to reference Vieira WP, Nobre CA, Filho JD, Vieira RM, Callado MR (2009) Meningitetuberculosaduranteterapia com infliximab (Tuberculosis meningitis during infliximab therapy). ActaRheumatol Port 34(4):681–682 Vieira WP, Nobre CA, Filho JD, Vieira RM, Callado MR (2009) Meningitetuberculosaduranteterapia com infliximab (Tuberculosis meningitis during infliximab therapy). ActaRheumatol Port 34(4):681–682
36.
go back to reference Parsons AM, Zuniga LA, Hoxworth JM, Lyons M, Aslam F, Goodman BP (2018) Rheumatoid meningitis: a case review. Neurologist 23(3):83–85CrossRefPubMed Parsons AM, Zuniga LA, Hoxworth JM, Lyons M, Aslam F, Goodman BP (2018) Rheumatoid meningitis: a case review. Neurologist 23(3):83–85CrossRefPubMed
37.
go back to reference Kemanetzoglou E, Andreadou E (2017) CNS demyelination with TNF-α blockers. CurrNeurolNeurosci Rep 17(4):36 Kemanetzoglou E, Andreadou E (2017) CNS demyelination with TNF-α blockers. CurrNeurolNeurosci Rep 17(4):36
38.
go back to reference Robinson WH, Genovese MC, Moreland LW (2001) Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum 44(9):1977–1983CrossRefPubMed Robinson WH, Genovese MC, Moreland LW (2001) Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum 44(9):1977–1983CrossRefPubMed
Metadata
Title
Aseptic meningitis in rheumatoid arthritis after anti-TNF administration: a case-based literature review
Authors
Reşit Yıldırım
Döndü Üsküdar Cansu
Deniz Arık
Suzan Saylısoy
Cengiz Korkmaz
Publication date
01-10-2021
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 10/2021
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-021-04822-6

Other articles of this Issue 10/2021

Rheumatology International 10/2021 Go to the issue